Robert I Tepper insider trades: Voyager Therapeutics (VYGR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
and 17 more companies
Open-market buys and sales
40 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | VYGR | ↓ Sell | 388,642 | $9.23 | $3.6M | Direct | Feb 1, 2023 (0d) |
| Jan 27, 2023 | VYGR | ↓ Sell | 50,000 | $9.02 | $451K | Direct | Jan 31, 2023 (4d) |
| Jan 25, 2023 | VYGR | ↓ Sell | 150,000 | $9.25 | $1.4M | Direct | Jan 26, 2023 (1d) |
| Jan 23, 2023 | VYGR | ↓ Sell | 155,000 | $9.12 | $1.4M | Direct | Jan 24, 2023 (1d) |
| Aug 25, 2022 | VYGR | ↓ Sell | 349,972 | $6.16 | $2.2M | Direct | Aug 26, 2022 (1d) |
| Aug 16, 2022 | VYGR | ↓ Sell | 128,456 | $6.04 | $776K | Direct | Aug 18, 2022 (2d) |
| Aug 15, 2022 | VYGR | ↓ Sell | 483,815 | $6.10 | $3.0M | Direct | Aug 16, 2022 (1d) |
| Jun 8, 2022 | RVMD | ↓ Sell | 419,901 | $20.25 | $8.5M | Direct | Jun 10, 2022 (2d) |
| Nov 12, 2021 | JNCE | ↓ Sell | 1,900,000 | $8.38 | $15.9M | Direct | Nov 16, 2021 (4d) |
| Jun 4, 2021 | RVMD | ↓ Sell | 543,113 | $30.21 | $16.4M | Direct | Jun 7, 2021 (3d) |
| May 26, 2021 | RVMD | ↓ Sell | 1,366,204 | $30.57 | $41.8M | Direct | May 27, 2021 (1d) |
| May 25, 2021 | JNCE | ↓ Sell | 552,520 | $8.00 | $4.4M | Direct | May 27, 2021 (2d) |
| Mar 1, 2021 | JNCE | ↓ Sell | 1,450,000 | $11.75 | $17.0M | Direct | Mar 3, 2021 (2d) |
| Jan 14, 2021 | RLAY | ↓ Sell | 2,811,197 | $40.74 | $114.5M | Indirect | Jan 14, 2021 (0d) |
| Jan 13, 2021 | RLAY | ↓ Sell | 2,811,197 | $40.06 | $112.6M | Direct | Jan 14, 2021 (1d) |
| Nov 19, 2020 | JNCE | ↓ Sell | 15,000 | $7.00 | $105K | Direct | Nov 23, 2020 (4d) |
| Nov 17, 2020 | JNCE | ↓ Sell | 15,000 | $7.25 | $109K | Direct | Nov 19, 2020 (2d) |
| Jul 22, 2019 | FULC | ↑ Buy | 81,250 | $16.00 | $1.3M | Direct | Jul 22, 2019 (0d) |
| Jul 23, 2018 | CNST | ↑ Buy | 266,667 | $15.00 | $4.0M | By Funds | Jul 24, 2018 (1d) |
| Jan 3, 2018 | MYOK | ↓ Sell | 816,326 | $42.00 | $34.3M | Direct | Jan 5, 2018 (2d) |
| Nov 6, 2017 | ALNA | ↑ Buy | 215,000 | $14.00 | $3.0M | Direct | Nov 6, 2017 (0d) |
| Oct 4, 2017 | CTMX | ↓ Sell | 24,777 | $24.34 | $603K | Direct | Oct 4, 2017 (0d) |
| Sep 26, 2017 | MYOK | ↓ Sell | 601,400 | $43.00 | $25.9M | Direct | Sep 27, 2017 (1d) |
| Sep 19, 2017 | CTMX | ↓ Sell | 20,000 | $18.00 | $360K | Direct | Sep 21, 2017 (2d) |
| Sep 11, 2017 | MYOK | ↓ Sell | 221,250 | $41.30 | $9.1M | Direct | Sep 12, 2017 (1d) |
| Jun 29, 2017 | CTMX | ↓ Sell | 15,000 | $16.00 | $240K | Direct | Jun 30, 2017 (1d) |
| Apr 6, 2017 | GBT | ↓ Sell | 31,225 | $33.23 | $1.0M | Direct | Apr 10, 2017 (4d) |
| Mar 27, 2017 | CTMX | ↓ Sell | 1,650,000 | $17.39 | $28.7M | Direct | Mar 27, 2017 (0d) |
| Mar 2, 2017 | GBT | ↓ Sell | 2,045,294 | $25.54 | $52.2M | Direct | Mar 6, 2017 (4d) |
| Feb 7, 2017 | BPMC | ↓ Sell | 1,000,000 | $35.27 | $35.3M | Direct | Feb 9, 2017 (2d) |
| Nov 14, 2016 | GBT | ↓ Sell | 2,000,000 | $19.36 | $38.7M | Direct | Nov 16, 2016 (2d) |
| May 16, 2016 | SAGE | ↓ Sell | 850,000 | $31.25 | $26.6M | Direct | May 18, 2016 (2d) |
| Sep 12, 2014 | BLUE | ↓ Sell | 125,000 | $36.54 | $4.6M | Indirect | Sep 12, 2014 (0d) |
| Jan 21, 2014 | BLUE | ↓ Sell | 250,000 | $23.91 | $6.0M | Indirect | Jan 23, 2014 (2d) |
| Jan 17, 2014 | BLUE | ↓ Sell | 307,000 | $22.43 | $6.9M | Indirect | Jan 17, 2014 (0d) |
| Jan 14, 2014 | BLUE | ↓ Sell | 340,000 | $21.90 | $7.4M | Indirect | Jan 14, 2014 (0d) |
| Feb 12, 2007 | MLNM | ↓ Sell | 22,500 | $11.36 | $256K | Direct | Feb 13, 2007 (1d) |
| Nov 20, 2006 | MLNM | ↓ Sell | 15,000 | $11.50 | $172K | Direct | Nov 20, 2006 (0d) |
| Oct 30, 2006 | MLNM | ↓ Sell | 60,000 | $11.87 | $712K | Direct | Oct 31, 2006 (1d) |
| Aug 9, 2006 | MLNM | ↓ Sell | 1,700 | $9.87 | $17K | Direct | Aug 10, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VYGR insiders
Open-market trades in the last 12 months
About Robert I Tepper's insider trades
Robert I Tepper is a 10% owner of Voyager Therapeutics (VYGR). Since Aug 9, 2006, Robert has reported 3 open-market purchases worth $8.3M and 37 sales worth $623.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (51 filings), conversions (22 filings), grants and awards (11 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VYGR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.